insights_auto
Why is KHTRF up 2,94%?
Dive Deeperchevron_right
KHTRF:OTCMKTS
Knight Therapeutics Inc
7,71 $
arrow_upward
+2,94%(+0,22) 1D
7,81 $
arrow_upward
+1,29% (+0,099)bedtimeAfter hours
Closed: 16 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KHTRF...
Open
7,71 $
High
7,71 $
Low
7,71 $
Mkt. cap
1,08 մլրդ
Avg. vol.
1,41 հզր
Volume
1,04 հզր
52-wk high
7,71 $
52-wk low
4,07 $
Beta
0,20
Shares outstanding
98,23 մլն
No. of employees
830
Open
7,71 $
High
7,71 $
Low
7,71 $
Mkt. cap
1,08 մլրդ
Avg. vol.
1,41 հզր
Volume
1,04 հզր
52-wk high
7,71 $
52-wk low
4,07 $
Beta
0,20
Shares outstanding
98,23 մլն
No. of employees
830
News stories
From web sources and news partners
Investing News Network
·
36 րոպե առաջ
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
MarketBeat
·
21 րոպե առաջ
CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock
Stocktwits
·
1 ժամ առաջ
Nasdaq 100 Records Worst Week In 18 Months As Investors Steer Clear Of Chipmakers — AAPL, MSTR, UBER, SOXX In Focus
Yahoo Finance
·
2 ժամ առաջ
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc